A Systematic Review of the Potential Chemoprotective Effects of Resveratrol on Doxorubicin-Induced Cardiotoxicity: Focus on the Antioxidant, Antiapoptotic, and Anti-Inflammatory Activities

Purpose. Although doxorubicin chemotherapeutic drug is commonly used to treat various solid and hematological tumors, its clinical use is restricted because of its adverse effects on the normal cells/tissues, especially cardiotoxicity. The use of resveratrol may mitigate the doxorubicin-induced card...

Full description

Bibliographic Details
Main Authors: Li-Feng Hu, Huan-Rong Lan, Xue-Min Li, Ke-Tao Jin
Format: Article
Language:English
Published: Hindawi Limited 2021-01-01
Series:Oxidative Medicine and Cellular Longevity
Online Access:http://dx.doi.org/10.1155/2021/2951697
id doaj-c684b64cf4364925a75c6ca694a35157
record_format Article
spelling doaj-c684b64cf4364925a75c6ca694a351572021-09-06T00:00:05ZengHindawi LimitedOxidative Medicine and Cellular Longevity1942-09942021-01-01202110.1155/2021/2951697A Systematic Review of the Potential Chemoprotective Effects of Resveratrol on Doxorubicin-Induced Cardiotoxicity: Focus on the Antioxidant, Antiapoptotic, and Anti-Inflammatory ActivitiesLi-Feng Hu0Huan-Rong Lan1Xue-Min Li2Ke-Tao Jin3Department of Colorectal SurgeryDepartment of Breast and Thyroid SurgeryDepartment of Hepatobiliary SurgeryDepartment of Colorectal SurgeryPurpose. Although doxorubicin chemotherapeutic drug is commonly used to treat various solid and hematological tumors, its clinical use is restricted because of its adverse effects on the normal cells/tissues, especially cardiotoxicity. The use of resveratrol may mitigate the doxorubicin-induced cardiotoxic effects. For this aim, we systematically reviewed the potential chemoprotective effects of resveratrol against the doxorubicin-induced cardiotoxicity. Methods. In the current study, a systematic search was performed based on Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guideline for the identification of all relevant studies on “the role of resveratrol on doxorubicin-induced cardiotoxicity” in the electronic databases of Web of Science, PubMed, and Scopus up to March 2021 using search terms in their titles and abstracts. Two hundred and eighteen articles were screened in accordance with a predefined set of inclusion and exclusion criteria. Finally, 33 eligible articles were included in this systematic review. Results. The in vitro and in vivo findings demonstrated a decreased cell survival, increased mortality, decreased heart weight, and increased ascites in the doxorubicin-treated groups compared to the control groups. The combined treatment of resveratrol and doxorubicin showed an opposite pattern than the doxorubicin-treated groups alone. Furthermore, this chemotherapeutic agent induced the biochemical and histopathological changes on the cardiac cells/tissue; however, the results (for most of the cases) revealed that these alterations induced by doxorubicin were reversed near to normal levels (control groups) by resveratrol coadministration. Conclusion. The results of this systematic review stated that coadministration of resveratrol alleviates the doxorubicin-induced cardiotoxicity. Resveratrol exerts these chemoprotective effects through several main mechanisms of antioxidant, antiapoptosis, and anti-inflammatory.http://dx.doi.org/10.1155/2021/2951697
collection DOAJ
language English
format Article
sources DOAJ
author Li-Feng Hu
Huan-Rong Lan
Xue-Min Li
Ke-Tao Jin
spellingShingle Li-Feng Hu
Huan-Rong Lan
Xue-Min Li
Ke-Tao Jin
A Systematic Review of the Potential Chemoprotective Effects of Resveratrol on Doxorubicin-Induced Cardiotoxicity: Focus on the Antioxidant, Antiapoptotic, and Anti-Inflammatory Activities
Oxidative Medicine and Cellular Longevity
author_facet Li-Feng Hu
Huan-Rong Lan
Xue-Min Li
Ke-Tao Jin
author_sort Li-Feng Hu
title A Systematic Review of the Potential Chemoprotective Effects of Resveratrol on Doxorubicin-Induced Cardiotoxicity: Focus on the Antioxidant, Antiapoptotic, and Anti-Inflammatory Activities
title_short A Systematic Review of the Potential Chemoprotective Effects of Resveratrol on Doxorubicin-Induced Cardiotoxicity: Focus on the Antioxidant, Antiapoptotic, and Anti-Inflammatory Activities
title_full A Systematic Review of the Potential Chemoprotective Effects of Resveratrol on Doxorubicin-Induced Cardiotoxicity: Focus on the Antioxidant, Antiapoptotic, and Anti-Inflammatory Activities
title_fullStr A Systematic Review of the Potential Chemoprotective Effects of Resveratrol on Doxorubicin-Induced Cardiotoxicity: Focus on the Antioxidant, Antiapoptotic, and Anti-Inflammatory Activities
title_full_unstemmed A Systematic Review of the Potential Chemoprotective Effects of Resveratrol on Doxorubicin-Induced Cardiotoxicity: Focus on the Antioxidant, Antiapoptotic, and Anti-Inflammatory Activities
title_sort systematic review of the potential chemoprotective effects of resveratrol on doxorubicin-induced cardiotoxicity: focus on the antioxidant, antiapoptotic, and anti-inflammatory activities
publisher Hindawi Limited
series Oxidative Medicine and Cellular Longevity
issn 1942-0994
publishDate 2021-01-01
description Purpose. Although doxorubicin chemotherapeutic drug is commonly used to treat various solid and hematological tumors, its clinical use is restricted because of its adverse effects on the normal cells/tissues, especially cardiotoxicity. The use of resveratrol may mitigate the doxorubicin-induced cardiotoxic effects. For this aim, we systematically reviewed the potential chemoprotective effects of resveratrol against the doxorubicin-induced cardiotoxicity. Methods. In the current study, a systematic search was performed based on Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guideline for the identification of all relevant studies on “the role of resveratrol on doxorubicin-induced cardiotoxicity” in the electronic databases of Web of Science, PubMed, and Scopus up to March 2021 using search terms in their titles and abstracts. Two hundred and eighteen articles were screened in accordance with a predefined set of inclusion and exclusion criteria. Finally, 33 eligible articles were included in this systematic review. Results. The in vitro and in vivo findings demonstrated a decreased cell survival, increased mortality, decreased heart weight, and increased ascites in the doxorubicin-treated groups compared to the control groups. The combined treatment of resveratrol and doxorubicin showed an opposite pattern than the doxorubicin-treated groups alone. Furthermore, this chemotherapeutic agent induced the biochemical and histopathological changes on the cardiac cells/tissue; however, the results (for most of the cases) revealed that these alterations induced by doxorubicin were reversed near to normal levels (control groups) by resveratrol coadministration. Conclusion. The results of this systematic review stated that coadministration of resveratrol alleviates the doxorubicin-induced cardiotoxicity. Resveratrol exerts these chemoprotective effects through several main mechanisms of antioxidant, antiapoptosis, and anti-inflammatory.
url http://dx.doi.org/10.1155/2021/2951697
work_keys_str_mv AT lifenghu asystematicreviewofthepotentialchemoprotectiveeffectsofresveratrolondoxorubicininducedcardiotoxicityfocusontheantioxidantantiapoptoticandantiinflammatoryactivities
AT huanronglan asystematicreviewofthepotentialchemoprotectiveeffectsofresveratrolondoxorubicininducedcardiotoxicityfocusontheantioxidantantiapoptoticandantiinflammatoryactivities
AT xueminli asystematicreviewofthepotentialchemoprotectiveeffectsofresveratrolondoxorubicininducedcardiotoxicityfocusontheantioxidantantiapoptoticandantiinflammatoryactivities
AT ketaojin asystematicreviewofthepotentialchemoprotectiveeffectsofresveratrolondoxorubicininducedcardiotoxicityfocusontheantioxidantantiapoptoticandantiinflammatoryactivities
AT lifenghu systematicreviewofthepotentialchemoprotectiveeffectsofresveratrolondoxorubicininducedcardiotoxicityfocusontheantioxidantantiapoptoticandantiinflammatoryactivities
AT huanronglan systematicreviewofthepotentialchemoprotectiveeffectsofresveratrolondoxorubicininducedcardiotoxicityfocusontheantioxidantantiapoptoticandantiinflammatoryactivities
AT xueminli systematicreviewofthepotentialchemoprotectiveeffectsofresveratrolondoxorubicininducedcardiotoxicityfocusontheantioxidantantiapoptoticandantiinflammatoryactivities
AT ketaojin systematicreviewofthepotentialchemoprotectiveeffectsofresveratrolondoxorubicininducedcardiotoxicityfocusontheantioxidantantiapoptoticandantiinflammatoryactivities
_version_ 1717780302694187008